Brief: Resonance Health Says acquisition of TrialsWest Group

Resonance Health

02/04/2024 04:36

April 2 (Reuters) - Resonance Health Ltd  RHT.AX :
    * TRIALSWEST IS EXPECTED TO CONTRIBUTE A$2 MILLION IN
REVENUE AND
A$0.67 MILLION IN EBITDA ON ANNUALISED BASIS 
    * ACQUISITION OF TRIALSWEST GROUP
    * CONTRACTED TO ACQUIRE 100% OF TRIALSWEST PTY LTD
    * WILL PAY UPFRONT CASH CONSIDERATION OF A$4 MILLION UNDER
TERMS
OF SHARE SALE AGREEMENT
    * FURTHER A$4 MILLION MAY BE PAYABLE TO TRIALSWEST VENDORS
UNDER
EARNOUT ARRANGEMENT SUBJECT TO CONDITIONS


Further company coverage:  RHT.AX 

 ((Reuters.Briefs@thomsonreuters.com;))